BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19909806)

  • 1. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P
    Biochim Biophys Acta; 2010 Dec; 1802(12):1178-87. PubMed ID: 19909806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro methods to assess 11β-hydroxysteroid dehydrogenase type 2 activity.
    Kley M; Moser SO; Winter DV; Odermatt A
    Methods Enzymol; 2023; 689():167-200. PubMed ID: 37802570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Displacement of cortisol from human heart by acute administration of a mineralocorticoid receptor antagonist.
    Iqbal J; Andrew R; Cruden NL; Kenyon CJ; Hughes KA; Newby DE; Hadoke PW; Walker BR
    J Clin Endocrinol Metab; 2014 Mar; 99(3):915-22. PubMed ID: 24423282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in Vitro triple screen model for human mineralocorticoid receptor activity.
    Liu H; Konzen S; Coy A; Rege J; Gomez-Sanchez CE; Rainey WE; Turcu AF
    J Steroid Biochem Mol Biol; 2024 Jun; 243():106568. PubMed ID: 38866188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genetic defect resulting in mild low-renin hypertension.
    Wilson RC; Dave-Sharma S; Wei JQ; Obeyesekere VR; Li K; Ferrari P; Krozowski ZS; Shackleton CH; Bradlow L; Wiens T; New MI
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10200-5. PubMed ID: 9707624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis.
    Gomez-Sanchez EP
    Steroids; 2014 Dec; 91():20-31. PubMed ID: 25173821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mammalian mineralocorticoid receptor: tying down a promiscuous receptor.
    Gomez-Sanchez EP
    Exp Physiol; 2010 Jan; 95(1):13-8. PubMed ID: 19648477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling drug-induced hypertension: molecular mechanisms of aldosterone-independent mineralocorticoid receptor activation by posaconazole.
    Sanchez-Niño MD; Ortiz A
    Clin Kidney J; 2018 Oct; 11(5):688-690. PubMed ID: 30289131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Qatari siblings with cystic fibrosis and apparent mineralocorticoid excess.
    Zahraldin K; Janahi IA; Ben-Omran T; Alsulaiman R; Hamad B; Imam A
    Ann Thorac Med; 2015; 10(1):69-72. PubMed ID: 25593612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent mineralocorticoid excess in Israel: a case series and literature review.
    Lebel A; Ben Shalom E; Mokatern R; Halevy R; Zehavi Y; Magen D
    Eur J Endocrinol; 2024 May; 190(5):347-353. PubMed ID: 38652803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression.
    Serrano-Morillas N; González-Alayón C; Vastola-Mascolo A; Rodríguez-Rodríguez AE; Hernández G; Porrini E; Hernández-Guerra M; Alvarez de la Rosa D
    Am J Physiol Gastrointest Liver Physiol; 2023 Oct; 325(4):G306-G317. PubMed ID: 37461846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule?
    Gomez-Sanchez EP
    Trends Endocrinol Metab; 2011 May; 22(5):179-87. PubMed ID: 21429762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Cortisone as a Novel Predictor of the Low-Renin Phenotype.
    Tapia-Castillo A; Carvajal CA; Pérez JA; Sandoval A; Allende F; Solari S; Fardella CE
    J Endocr Soc; 2024 Apr; 8(6):bvae051. PubMed ID: 38586159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central regulation of blood pressure by the mineralocorticoid receptor.
    Gomez-Sanchez EP; Gomez-Sanchez CE
    Mol Cell Endocrinol; 2012 Mar; 350(2):289-98. PubMed ID: 21664417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations About the Indirect Role of Low Cortisone in Subjects With Normal Cortisol to Cortisone Ratio.
    Armanini D; Censi S; Bordin L; Andrisani A; Sabbadin C
    J Endocr Soc; 2024 May; 8(7):bvae095. PubMed ID: 38813396
    [No Abstract]   [Full Text] [Related]  

  • 16. Monogenic Etiology of Hypertension.
    Singh V; Van Why SK
    Med Clin North Am; 2024 Jan; 108(1):157-172. PubMed ID: 37951648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action.
    Chapman K; Holmes M; Seckl J
    Physiol Rev; 2013 Jul; 93(3):1139-206. PubMed ID: 23899562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent use of corticosteroids with licorice-containing TCM preparations in Taiwan: a National Health Insurance Database study.
    Liao HL; Ma TC; Li YC; Chen JT; Chang YS
    J Altern Complement Med; 2010 May; 16(5):539-44. PubMed ID: 20438302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent Mineralocorticoid Excess Caused by a Novel Mutation in 11-β Hydroxysteroid Dehydrogenase Type 2 Enzyme: Its Genetics and Response to Therapy.
    Alzahrani AS; Aljuhani N; Qasem E; Almohanna M; Hamoudh E; AlOmair A; Alharbi N
    Endocr Pract; 2014 Sep; 20(9):e151-6. PubMed ID: 24936560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 11 beta-hydroxysteroid dehydrogenase in the pathogenesis of hypertension.
    van Uum SH; Hermus AR; Smits P; Thien T; Lenders JW
    Cardiovasc Res; 1998 Apr; 38(1):16-24. PubMed ID: 9683905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.